Fast, $17.5B Deal Lands Waters Corp. in IVD Market

By Janette Wider | From the Volume XXXII, No. 11 – August 4, 2025 Issue

WHEN BECTON DICKINSON  (BD) ANNOUNCED ITS INTENT to spin off its in vitro diagnostics (IVD) and life sciences units in February, few observers expected a deal to close just five months later. But now that such an agreement has occurred as of July 14, the buy…

Read More

---

July 14, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 10 – July 14, 2025 Issue

Clinical laboratories across the country that have not prepared for the potential of increased measles testing may want to consider doing so. On July 7, The Washington Post reported that US measles cases had reached a 33-year high, based on data collected by the Johns Hopkins Center for…

Read More

---

Leveraging Data to Create Lab and Healthcare Efficiencies

By Robert Michel | From the Volume XXXII, No. 8 – June 2, 2025 Issue

CEO SUMMARY: In this exclusive interview with The Dark Report, Bradley Bostic, founder, chair, and CEO of healthcare and laboratory data intelligence company hc1 discusses trends in healthcare, how to position clinical laboratories as a strategic asset, and ways to analyze…

Read More

---

September 23, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki t…

Read More

---

June 10, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 8 – June 10, 2024 Issue

Once a high-flier lab test manufacturer with a market valuation of $2 billion, Cue Health of San Diego filed for Chapter 7 bankruptcy on May 28. Analysts now say the company is valued at about $15 million. Founded in 2010, Cue Health was developing a test system that consumers could …

Read More

---

February 26, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue

Following an investment of $1.75 million, officials at University of Maine at Augusta (UMA) opened a new lab facility this month that allows it to double the number of medical laboratory technicians it can train, from eight to 10 to as many as 20. In its coverage of the new training …

Read More

---

December 26, 2023, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue

Is the world ready for a diagnostic service that performs a whole genome sequence of embryos conceived by in vitro fertilization? That’s the business plan announced on Dec. 5 by San Francisco-based Orchid Health. In covering this development, Science wrote, “Find the emb…

Read More

---

IVD and Lab Consolidation Reduces Choices for Labs

By Robert Michel | From the Volume XXX, No. 13 – September 11, 2023 Issue

CEO SUMMARY: Since the launch of The Dark Report in 1995, consolidation of hospitals, physician groups, clinical labs, pathology groups, and IVD manufacturers has been a major trend every year. Toda…

Read More

---

January 23, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue

New data from the Association of American Medical Colleges (AAMC) offers further evidence of a decreasing talent pool of pathologists in the United States. Active physicians in anatomic and clinical pathology dropped from 13,201 in 2016 to 12,180 in 2021—a 7.7% decrease, according to the AAM…

Read More

---

Top Public IVD Companies Report Q3/Q4 2022 Earnings

By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue

IT WAS A MIXED BAG OF THIRD QUARTER FINANCIAL RESULTS for the nation’s largest in vitro diagnostics (IVD) manufacturers, with COVID-19 testing volume a contributing factor.  Fluctuating demand for SARS-CoV-2 testing proved perplexing, as some IV…

Read More

---